The combination of GA and DEX could restore the imbalance between oxidant/antioxidant parameters and induce a significant increase in GSH and a significant decrease in MDA, NF-κB, and HMGB1 expression, indicating that GA-DEX combination therapy could be a promising strategy for managing LPS-induced AKI. The gene discussed is NFKB1; the disease is acute kidney injury.